{"meta":{"query_hash":"6a1be6e32de8","filters":{"venue":"Innovare Journal of Life Sciences"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6a1be6e32de8","api":"https://metacan.xera.ac/api/v1/cohort?venue=Innovare+Journal+of+Life+Sciences"},"results":[{"id":"W4200208170","doi":"10.22159/ijls.2021.v9i6.43430","title":"BIOSIMILARS: OPPORTUNITIES, CHALLENGES, AND THE GENERAL PRINCIPLES GOVERNING THEIR DEVELOPMENT AROUND THE GLOBE","year":2021,"lang":"en","type":"article","venue":"Innovare Journal of Life Sciences","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Globe; Agency (philosophy); European union; Medicine; Business; European market; International trade","score_opus":0.18433919910895252,"score_gpt":0.31571218571453524,"score_spread":0.13137298660558272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200208170","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014738208,0.43386102,0.047943287,0.314411,0.013008998,0.00071001146,0.00083979906,0.0005709536,0.17391673],"genre_scores_gemma":[0.10804947,0.59038365,0.11396295,0.124964006,0.0094575565,0.0008676896,0.0012045081,0.00047311987,0.050636973],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9757219,0.005154403,0.0035915754,0.002049194,0.0121151935,0.0013677427],"domain_scores_gemma":[0.9793243,0.007385097,0.0033547417,0.0015987606,0.006660696,0.0016763491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026784886,0.0008204116,0.00084257446,0.00285051,0.0024743748,0.0132393325,0.0018832056,0.009631991,0.005289657],"category_scores_gemma":[0.025544705,0.0006858263,0.0009632972,0.0033072145,0.0076856725,0.010694636,0.0034693354,0.01115345,0.002482585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009304641,0.00019176607,0.0014092161,0.0023935388,0.000035671004,0.0007326471,0.0015668637,0.0012421873,0.0052611926,0.6243334,0.07250668,0.29023385],"study_design_scores_gemma":[0.000018869696,0.00010135348,0.0011577961,0.0019640643,0.000015023873,0.00060185225,0.0005912493,0.00028807897,0.0013806206,0.055024717,0.938798,0.000058501904],"about_ca_topic_score_codex":0.005058947,"about_ca_topic_score_gemma":0.0030272,"teacher_disagreement_score":0.026784886,"about_ca_system_score_codex":0.004809796,"about_ca_system_score_gemma":0.013251466,"threshold_uncertainty_score":0.14165372},"labels":[],"label_agreement":null}]}